drugset / Trial / NCT03514771

Early Non-Ablative Fractional Laser Resurfacing for Acne Scars After Treatment With Oral Isotretinoin

NCT03514771

Completed 15 enrolled David Smart
NaSingle-groupSingle-blindTreatment

Summary

Patients who have completed have completed a cumulative dose of \>=120miligram/kilogram oral isotretinoin within the last 30 days, and has mild to moderate acne scarring will be randomized, into a right-left comparison study using Fraxel DUAL (Solta Medical) laser on one side of the face, and no treatment on the other side of the face. Subejcts will receive treatments at week 0, week 4, and week 8. Photographs will be taken after each treatment, 7 days after each treatment, and 4 months after last treatment. Photographs will be reviewed by blind assessors who will analyze the pre- and post-treatment photographs to measure change.

Timeline

Start
2016-01-28
Primary completion
2017-03-14
Completion
2017-06-14

Drugs

EvaluationDrugModalityDoseRoute
Background Isotretinoin Other / unclassified 120 mg/kg Oral
Background Valacyclovir Unknown 1 g Oral

Indications